3,332
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Optimizing Test and Treat in Malawi: health care worker perspectives on barriers and facilitators to ART initiation among HIV-infected clients who feel healthy

ORCID Icon, , , , , & show all
Article: 1728830 | Received 31 Oct 2018, Accepted 24 Dec 2019, Published online: 26 Feb 2020

References

  • Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–8.
  • Ford N, Migone C, Calmy A, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS. 2018;32:17.
  • World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infections; 2016 recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2015.
  • UNAIDS. Begining of the end of the AIDS epidemic. The gap report. Geneva: UNAIDS; 2014.
  • World Health Organization. Treat all: policy adoption and implementation status in countries. Geneva: World Health Organization; 2017.
  • Kazanjian P. UNAIDS 90-90-90 campaign to end the AIDS epidemic in historic perspective. Milbank Q. 2017;95:408–439.
  • Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505. PubMed PMID: 21767103.
  • Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
  • Siedner MJ, Ng CK, Bassett IV, et al. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis. 2015 Apr 1;60:1120–1127. PubMed PMID: 25516189; PubMed Central PMCID: PMC4366582.
  • Bor J, Ahmed S, Fox MP, et al. Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without further investment in testing, linkage and initiation. Oral presentation at International AIDS Society; Durban, South Africa; 2016.
  • Ahmed S, Autrey J, Katz IT, et al. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low-and middle-income countries. Soc Sci Med. 2018;213:72–84.
  • Horter S, Bernays S, Thabede Z, et al. “I don’t want them to know”: how stigma creates dilemmas for engagement with treat-all HIV care for people living with HIV in Eswatini. Afr J AIDS Res. 2019;18:27–37.
  • Seeley J, Bond V, Yang B, et al. Understanding the time needed to link to care and start ART in seven HPTN 071 (PopART) study communities in Zambia and South Africa. AIDS Behav. 2019;23:929–946.
  • Katz IT, Bangsberg DR. Cascade of refusal-what does it mean for the future of treatment as prevention in sub-Saharan Africa? Curr HIV/AIDS Rep. 2016;13:125–130. PubMed PMID: 26894487; eng.
  • Chadambuka A, Katirayi L, Muchedzi A, et al. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (option B+) in selected health facilities in Zimbabwe: a qualitative study. BMC Public Health. 2017;18:57.
  • MH ZA K, Mazenga A, Ahmed S, et al. Why did I stop? Barriers and facilitators to uptake and adherence to ART in option B+ HIV care in Lilongwe, Malawi. PLOS One. 2016;11(2):e0149527.
  • Clouse K, Schwartz S, Van Rie A, et al. “What they wanted was to give birth; nothing else”: barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014;67:e12–e18. PubMed PMID: 00126334-201409010-00019.
  • McLean E, Renju J, Wamoyi J, et al. ‘I wanted to safeguard the baby’: a qualitative study to understand the experiences of option B+ for pregnant women and the potential implications for ‘test-and-treat’ in four sub-Saharan African settings. Sex Transm Infect. 2017;93:e052972.
  • Leeman J, Sandelowski M. Practice‐based evidence and qualitative inquiry. J Nurs Scholarship. 2012;44:171–179.
  • National Statistics Office. Demographic and health survey. Zomba (Malawi): NSO; Rockville (MD): ICF; 2015–2016.
  • Malawi Ministry of Health; Dept of HIV and AIDs. Malawi guidelines for clinical management of HIV in children and adults. 3rd ed. Lilongwe (Malawi): HIV Unit; 2016.
  • Ministry of Health Malawi. Integrated HIV program report (January–March 2017). Lilongwe (Malawi): HIV Unit; 2017.
  • GmbH. Atlas.ti v.7. Berlin: Scientific Sofware Development GmbH; 1989.
  • Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. San Jose State University (USA): Sage Publications; 2008.
  • Kaler A, Nicole Angotti RA. “They are looking just the same”: antiretroviral treatment as social danger in rural Malawi. Soc Sci Med. 2016;167:71–78.
  • Conroy A, Yeatman S, Dovel K. The social construction of AIDS during a time of evolving access to antiretroviral therapy in rural Malawi. Cult Health Sex. 2013;15:924–937.
  • MacPherson P, MacPherson EE, Mwale D, et al. Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi. J Int AIDS Soc. 2012 Dec 31;15:18020. PubMed PMID: PMC3535694.
  • Shigaki C, Kruse RL, Mehr D, et al. Motivation and diabetes self-management. Chronic Illn. 2010;6:202–214.
  • Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther. 2016 Aug 9;33:1740–1754. PubMed PMID: PMC5055556.
  • Katz IT, Dietrich J, Tshabalala G, et al. Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav. 2015 Apr;19:704–714. PubMed PMID: 25304330; PubMed Central PMCID: PMCPMC4393756.
  • Mbonye M, Seeley J, Nalugya R, et al. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala. AIDS Care. 2016;28:33–38.
  • Horter S, Thabede Z, Dlamini V, et al. “Life is so easy on ART, once you accept it”: acceptance, denial and linkage to HIV care in Shiselweni, Swaziland. Soc Sci Med. 2017 Mar;176:52–59. PubMed PMID: 28129547.
  • Curran K, Ngure K, Shell-Duncan B, et al. ‘If I am given antiretrovirals I will think I am nearing the grave’: kenyan HIV serodiscordant couples’ attitudes regarding early initiation of antiretroviral therapy. AIDS. 2014 Jan 14;28:227–233. PubMed PMID: 24413310; PubMed Central PMCID: PMCPMC4040408.
  • Roura M, Urassa M, Busza J, et al. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect. 2009 Nov 26;85:308–312. PubMed PMID: PMC2708343.
  • Ware NC, Wyatt MA, Geng EH, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013;10:e1001369.
  • Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, et al. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010;15:1347–1356.
  • Nachega JB, Uthman OA, Del Rio C, et al. Addressing the achilles’ heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59:S21–S27. PubMed PMID: PMC4141496.
  • Dovel K. Shifting focus from individuals to institutions: the role of gendered health institutions on men’s use of HIV services. Denver (CO): University of Colorado; 2016.
  • Watkins S, Santow G, Bracher M, et al. Epistemology and epidemiology: diagnosing AIDS in rural Malawi. UCLA CCPR Population Working Papers; 2007: CCPR Population Working Papers 2007. 2017 Aug 21.
  • Fox MP, Rosen S, Geldsetzer P, et al. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. J Int AIDS Soc. 2016 Aug 8;19:20888. PubMed PMID: PMC4978859.
  • Bemelmans M, Baert S, Goemaere E, et al. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health. 2014;19:968–977.
  • Ellman T. Demedicalizing AIDS prevention and treatment in Africa. N Engl J Med. 2015;372:303–305. PubMed PMID: 25607425.
  • Duncombe C, Rosenblum S, Hellmann N, et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health. 2015;20:430–447.
  • Benjamin Young M, Hart RLD, Buchacz K, et al., for the HIV Outpatient Study (HOPS). HIV viral load monitoring frequency and risk of treatment failure among immunologically stable HIV-infected patients prescribed combination antiretroviral therapy. J Int Assoc Provid AIDS Care. 2015 Aug 20;14:6.
  • Mody A, Roy M, Sikombe K, et al. Improved retention with 6-month clinic return intervals for stable human immunodeficiency virus-infected patients in Zambia. Clinl Infect Dis. 2017;66:237–243.
  • Young B, Hart RLD, Buchacz K, et al. HIV viral load monitoring frequency and risk of treatment failure among immunologically stable HIV-infected patients prescribed combination antiretroviral therapy. JIAPAC. 2015 Nov–Dec 8/20;14:536–543. PubMed PMID: PMC4657746.
  • Miller CM, Ketlhapile M, Rybasack-Smith H, et al. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15:48–54. PubMed PMID: PMC3060335.
  • Hardon AP, Akurut D, Comoro C. Hunger,waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658–665.
  • Derksen L, Muula A, Matengeni A, et al. Reducing stigma and increasing HIV testing with a health information intervention: a cluster-randomized trial from Malawi. Vancouver (BC): IAS; 2015.
  • Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371:1603–1611.
  • Bor J, Herbst AJ, Newell ML, et al. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013 Feb 22;339:961–965. PubMed PMID: 23430655.
  • Kralik D, Koch T, Price K, et al. Chronic illness self-management: taking action to create order. J Clin Nurs. 2004;13:259–267.
  • Russell S, Seeley J. The transition to living with HIV as a chronic condition in rural Uganda: working to create order and control when on antiretroviral therapy. Soc Sci Med. 2010 Feb 1;70:375–382.
  • Kübler-Ross E, Wessler S, Avioli LV. On death and dying. JAMA. 1972;221:174–179.
  • Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care. Diabetes Care. 2001;24:695.
  • Satin DJ, Swenson SA, Stovitz SD. Effectively engaging patients in everyday health-care decisions. J Fam Pract. 2017;66(10):E1–E6.
  • Mitchell Christopher G, LN L. A multidimensional conceptual framework for understanding HIV/AIDS as a chronic long-term illnes. Soc Work. 2004;49:469–477.
  • Russell S, Seeley J. The transition to living with HIV as a chronic condition in rural Uganda: working to create order and control when on antiretroviral therapy. Soc Sci Med. 2010;70:375–382.
  • Kenedi CA, Goforth HW. A systematic review of the psychiatric side-effects of efavirenz. AIDS Behav. 2011 Nov 1;15:1803–1818.
  • Renju J, Moshabela M, McLean E, et al. ‘Side effects’ are ‘central effects’ that challenge retention in HIV treatment programmes in six sub-Saharan African countries: a multicountry qualitative study. BMJ. 2017;23:e052971.
  • Rutherford GW, Horvath H. Dolutegravir plus two nucleoside reverse transcriptase inhibitors versus efavirenz plus two nucleoside reverse transcriptase inhibitors as initial antiretroviral therapy for people with HIV: a systematic review. Plos One. 2016;11:e0162775.